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THE  PRESENCE  OF  PROTECTIVE  SUBSTANCES  IN 
HUMAN  SERUM  DURING  LOBAR  PNEUMONIA.* 
BY A.  R.  DOCHEZ,  M.D. 
(From  the  Hospital  of  The  Rockefeller  Institute  for  Medical  Research, 
New  York.) 
As  long  ago  as  I89I ,  G.  and  F.  Klemperer  1  showed  that  the 
blood of patients who had recovered from an attack of pneumonia 
might protect rabbits against infection with pneumococcus.  Since 
then Neufeld and Haendel  2 have also demonstrated that such sera 
may have protective power, not only for rabbits but for mice as well. 
Other observers have found that this property of post-cri'tical  blood 
serum is not constant, and Strouse,  3 and Seligmann and Klopstock,  4 
have even failed to  demonstrate it in any instance.  The observa- 
tions previously mentioned, however, seem to indicate that such pro- 
tective  substances  may  be  present  at  the  time  of  the  crisis  or 
afterward. 
Considerable  speculation  has  been  indulged  in,  and  no  little 
work carried on in order to bring the development of this protect- 
ive  power  into  direct  causal  relationship  with  the  crisis  in  this 
disease.  The crisis  is  such a  clear-cut, striking phenomenon that 
it would seem that it may depend on some single cause or relatively 
simple biological  reaction, such as  the  destruction of the bacteria 
by immune substances or neutralization of toxin by antitoxin.  If 
the blood  of animals recovering from the  disease  constantly con- 
tains protective substances,  it  would be reasonable to  assume that 
the crisis  and  recovery occur because of the  development of such 
substances. 
Observations have also been made to determine the variety of the 
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immune  bodies  developing  in  the  blood,  to  which  the  protective 
power  is  due.  G.  and  F.  Klemperer  considered  the  protective 
power dependent upon an antitoxic  action of the serum.  R6mer  5 
holds  the  opinion  that  the  chief  action  is  bactericidal;  while  re- 
cently much stress  has  been laid  on  the  development of opsonins 
or bacteriotropins in the serum.  In the absence of the demonstra- 
tion  of a  pneumococcus toxin,  the view that  the protective power 
may be  due  to  an  antitoxin  is  purely hypothetical.  Even  RSmer 
has not been able to demonstrate the bactericidal power in vitro of 
post-pneumonia  serum.  Virulent  pneumococci are  so  resistant  to 
the action of opsonins,  as  detected by the ordinary technique,  that 
even  artificial  immune  sera,  having  far  greater  protective  power 
than  any post-critical sera so  far  studied,  show  very slight  if  any 
increase  in  opsonic  power  for  such  virulent  organisms.  By  the 
use  of  a different  technique,  Neufeld  and  Haendel  have  demon- 
strated  that  such post-critical sera  may show  an  increase of *heir 
property of favoring phagocytosis, both in vivo and in vitro.  This 
property, they consider, depends on the presence of bacteriotropins. 
In the effort to  find an explanation  of the crisis,  however, it  is 
of  great  importance  to  determine  definitely  whether  protective 
substances appear constantly in the post-critical serum, and whether 
the time of their appearance bears  any relationship to  the  time of 
crisis  or  recovery.  The  mere  demonstration  of  the  occasional 
presence of protective  substances  in  post-critical  sera  is  not  suffi- 
cient to permit drawing any conclusions as  to their relationship to 
the  phenomenon. 
The blood obtained  from a  series of patients has  therefore been 
studied to determine whether such substances are presen~t, and if so, 
to  determine  the  time  of  their  appearance.  No  effort  has  been 
made to determine the kind of immune bodies present. 
EXPERIMENTAL  PART. 
Methods.--The sera for the experiments presented in this paper 
were  obtained  by  venous  puncture  of  patients  with  typical  lobar 
pneumonia.  The blood  was  allowed to  clot,  the  serum  separated, 
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and  kept  in  the  dark  on  ice  until  used.  The  organism  employed 
in  each  experiment  was  obtained,  when  possible,  either  from  the 
blood or sputum of the patient whose serum was to be tested.  The 
organism in each instance was isolated before ~he  occurrence of the 
crisis.  It  has  been  found of some service,  in  procuring  pure  cul- 
tures  from sputum,  to  inject at the  same time  a  small  quantity  of 
human  serum which  seems to  inhibit  the growth  of contaminating 
bacteria.  In  case  the  pneumococcus,  when  isolated,  was  of  low 
pathogenicity,  the  virulence  was  raised  by  successive animal  pas- 
sages until a  dose of o.oooooi of a  cubic centimeter of a broth cul- 
ture was sufficient to kill.  White mice of as nearly the same age and 
size  as possible were used  as experimental  animals.  Twenty-four 
hour broth cultures fresh from animals were used for infection, and 
the serum and culture to be tested were mixed in varying quantities 
in the barrel  of  a  syringe  and  immediately  injected  intraperitone- 
ally.  The  animals  were  watched  for  from  five  to  ten  days,  ac- 
cording to the rate at which the culture killed,  and those surviving 
this time were considered protected.  A  small number of sera were 
tested  for  protective  power  against  a  typical  laboratory  strain  of 
pneumococcus;  in  all  other  instances,  the  sera  were tested  against 
homologous  strains  isolated  from  the  patients. 
PROTECTIVE  POWER  OF HUMAN  SERA AGAINST  A  TYPICAL 
PNEUMOCOCCUS. 
Experiment  1.--Serum t23  was  obtained from  a  patient with  typical pneu- 
monia of the right lower lobe.  The temperature fell by lysis on the seventh day 
of the disease.  The temperature again rose the next day and remained slightly 
elevated  for  about six  days.  The blood culture was  negative.  The  organism 
used  for  infection was  pneumococcus  Neufeld  I,  a  strain  of  constant  high 
virulence for  animals. 668  Protective  Substances in Human  Serum. 
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Experiment e.--The  serum  (4o5)  for  this test was  obtained  from  a  patient 
with partial pneumonic consolidation of  the left  lower  lobe. The  temperature 
fell  by  lysis  from  the  eighth  to  the  ninth  day  of  the  disease  and  remained 
normal.  The blood  culture was  negative.  The  protective power  of  the  serum 
was tested against pneumococcus Neufeld I. 
Quan-  Serum 405, 
Quantity  Dec. x  4,  tity of  Virulence ;  Control  se:  x  xx, frame- 
of culture  serum in  no serum,  rum, sypht-  ~'~tely be- 
in e.e.  c.c.  lis.  fore begin- 
aing of lysis. 
o  ooooooooooo°°°°°°°°°  ii!  ii!iiiii 
D.  i8  hrs. 
D.  I8 hrs. 
D,  24  hrs. 
D.  24 hrs. 
D.  28 hrs. 
D.  36 hrs. 
Serum 405, Dec. 
sS, ~t9~z, 6  hours 
after tempera- 
ture reached 
normal. 
D.  18 hrs. 
D.  I8 hrs. 
D.  I8 hrs. 
D. 36 hrs. 
D, 36 hrs. 
D. 48 hrs. 
Serum 405, Dec. 
ax, t9xx, 6 days 
after tempera- 
ture reached 
normal. 
D.  24 hrs. 
D, 24 hrs, 
D.  24 hrs. 
D. 28 hrs. 
D. 48 hrs. 
Serum4o  5, 
Jan. a,x~ra, 
x8 daysafter 
temperature 
reached nor- 
mal. 
D.  18  hrs. 
D.  18 hrs. 
D.  28 hrs. 
D.  28 hrs. 
D. 48  hrs. 
Experiment 3.--The patient whose serum  (418)  was used in this experiment 
had a short pneumonia, terminating by lysis from the fourth to the sixth day of 
the disease.  The blood culture was negative.  Protection for animals was tested 
against the stock laboratory pneumococcus Neufeld I. 
Quantity  Quantity 
of culture  of serum  Viruleace ; 
in c.c.  in c.c.  no serum.  I 
o.I 
O.OI 
O.OO1 
O,OOOI 
O.O000I 
O.OOOOOI 
Control  serum, 
syphilis. 
0.2  ~  [  -- 
0.2  1  0.2 
0.2  D. 18 hrs.  D. 24 hrs. 
0.2  D. 36 hrs.  I  D. 48 hrs. 
o.2  D.  28 hrs.J  D. 28 hrs. 
Serum 4x8, 
Dec. 24, x9xx, 
days before 
begiunin E of 
lysis. 
D. I8 hrs. 
D° x8 hrs. 
D. 28 hrs. 
D. 36 hrs. 
D.  28 hrs. 
Serum 4x8, 
Dec. 29, x9xz, 
xst day ofnorma| 
temperature. 
D.  28 hrs. 
D. 36 hrs. 
D. 36 hrs. 
Serum 4xS, 
Jan. 8, x9xa, 
xo days after 
first normal 
temperatUreo 
D.  I8 hrs. 
D,  28 hrs, 
D. i8 hrs. 
D.  28 hrs. 
D.  28 hrs. 
D. 36 hrs, 
PROTECTIVE  POWER  OF  HUMAN  SERA  AGAINST  HOMOLOGOUS 
PNEUMOCOCCI. 
Experiment  4.--The  serum  (119)  for  this  experiment  was  obtained  from 
a  patient  with typical  lobar  pneumonia,  terminating by  lysis  on  the  tenth  day, 
although  the  temperature  remained  slightly  elevated  for  six  days  thereafter. 
The pneumococcus  used  for infection was  obtained  from the patient's  blood on 
the  seventh  day  of  the  disease.  When  first  isolated,  o.5  c.c.  of  a  twenty-four 
hour  broth culture  failed to  kill a mouse.  The virulence was  raised  by succes- 
sive  animal passages  until o.oooooi  c.e.  was  fatal  for  mice in  forty-eight  hours. .~-~ ~  . 
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Experiment  5.--The  serum  (132)  was  obtained  from  a  patient  with  lobar 
pneumonia,  terminating by lysis  on  from  the  third to  the  sixth  day  of  the  dis- 
ease.  The  pneumococcus  against  which  the  specimens  of  sera  were  tested  was 
isolated  from  the  sputum,  and  the  virulence  raised  by  animal  passage  until 
o.oooi  c.c.  was  fatal  for  mice  in  forty-eight  hours.  The  blood  culture  was 
negative. 
Quantity of 
culture in 
c.c. 
0.I 
O.OI 
0.OOI 
O.OOOI 
0.0000I 
O.O0000I 
)uau. 
[ty ot  Virulence ; 
eruIE  !  no Serum. 
nc.c 
I 
--  j-- 
o.2  D. 3o hrs 
o.2  ]D. 41  hrs 
0.2  D. 4x hrs 
0.2  D. 4x hrs 
o.2  Survived. 
o.2  iSurvived. 
Control 
sertlm, endo 
cardltis. 
D. 3o hrs 
D. 41 hrs 
Survived. 
,Survived. 
Survived. 
Survived. 
Serum z32, 
Apr. t 7, 
x9xx, x day 
before drop 
in tem- 
perature. 
D. 4x hrs 
D. 30 hrs 
Survived. 
Survived. 
Survived. 
Survived. 
Serum x32, 
Apr. x8, x9xx, 
during falling 
temperature. 
D. 30  hrs. 
Survived. 
Survived. 
Survived. 
Survived. 
Survived. 
Serum X32, 
Apr. 2o,  x9xx, 
a days after drop 
in temperature. 
Patient still 
febrile. 
D. 4x hrs. 
Survived. 
Survived. 
Survived. 
Survived. 
Survived. 
Serum x32  , 
Apr. 2  3  , 
x9xx, 5 days 
after  drop 
in tempera- 
ture.  Pa- 
tient  afebrile. 
D. 41 hrs. 
Survived. 
Survived. 
Survived. 
Survived. 
Survived. 
Experiment  6.--The  patient  from  whom  the  serum  (145)  used  in  this 
experiment  was  obtained  had  typical  lobar  pneumonia.  The  temperature  fell 
by lysis on the ninth day of the disease,  rose again the next day,  and  remained 
slightly elevated until the fifteenth day,  when it again returned to  normal.  The 
patient  died  thirty  days  later  from  a  post-pneumonic nephritis.  The  organism 
was  obtained  from  the  sputum  and  was  the  so  called  Pneumoeoecus  mucosus. 
It  was  of  extremely  high virulence  for  mice.  The  blood  culture  was  negative. 672  Protective Substances  in Human  Serum. 
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Experiment  7.--The  serum  (411)  for  the  following  test  was  obtained  from 
a  patient,  with  severe  lobar  pneumonia,  involving  both  lower  lobes.  The  tem- 
perature  fell  by  lysis  on  the  seventh  day  of  disease,  reaching  normal  ten  days 
later.  The  blood  culture yielded  Diplococcus  lanceolatus.  The  organism,  when 
isolated,  was  of  low  virulence  for  mice,  o.I  c.c.  of  a  twenty-four  hour  broth 
culture  failing  to  kill.  Before  testing  the  protective  power  of  the  patient's 
serum, the virulence was raised by animal passage until o.oooooi  c.c. of a  twenty- 
four hour  broth  culture  was  fatal  for  mice  in  forty-eight  hours. 
Quantity 
of culture 
in c.c. 
Quantity 
of serum 
in c.c. 
0.I  0.2 
o.oI  0.2 
0.00I  0.2 
0.000I  0.2 
0.000,0I  0.2 
0.00000I  0.2 
Virulence ; 
no serum. 
D. 36 hrs. 
D. 5 days. 
D, 24 hrs. 
D.  36 hrs. 
Control serum, 
syphilis. 
l 
D. 36 hrS. 
D. 36 hrS. 
D. 28 hrs. 
D. 28 hrs. 
Serum 4zz, Dec. 
z6, zgz*, 3 days 
before begin- 
ning of lysis. 
D.  I8 hrs. 
D.  I8 hrs. 
D. I8 hrs. 
D.  18 hrs. 
D. 24 hrs. 
D. $ days. 
Serum4xx. Dec. 
*9, r9z*,  dur- 
ing lysis. 
D.  18 hrs. 
D. 24 hrs. 
Survived. 
D. 54 hrs. 
D. 36 hrs. 
Survived. 
Serum 4xx, Jan. 
3, *9  *u, *4 days 
after tempera- 
ture reached 
normal. 
D. I8 hrs. 
D. 4 days. 
Survived. 
Survived. 
Experiment  8.--The  serum  (503)  for  this  experiment  was  obtained  from  a 
typical  case  of  lobar  pneumonia,  terminating  by  crisis  on  the  eighth day  of  the 
disease.  The  blood  cultures  during  the  course  of  the  disease  were  negative. 
The  protective  power  of  the  serum  was  tested  against  two  strains  of  pneumo- 
cocci;  one,  pneumococcus  X,  a  stock  culture,  had  received  a  great  number  of 
animal  passages;  the  other,  pneumococcus  IX,  had  been  isolated  from  the 
sputum  of  the  patient  and  passed  through  five  animals  until  o.00ooo1  c.c.  of  a 
twenty-four  hour  broth  culture  was  fatal  for  mice in  forty-eight  hours.  It  was 
possible  to  protect  mice  against  infection  with  both  strains  by  the  use  of  the 
serum  of a  horse  immunized to  a  single strain of pneumococcus  Neufeld  I. 
Protection  of  Mice  against  Pneumococcus X  (Stock  Organism). 
Quantity of  Quan- 
culture in  tity of 
C.C.  serum  in 
c.c. 
0.I  0.2 
O.OI  O.2 
0.OO~  0.2 
0.O00I  0.2 
O.O000I  O.2 
0.0OOOOI  0.2 
Virulence;  Immune  I Se 
no s  .....  Ih  ..........  [x9~ 
--  Survived. / 
--  ISurvived. [ 
D.  3 6  hrs. Survived. ]D. 
D. 36 hrs.[Survived. [D, 
D. 36 hrs.[Survived. [D. 
D.  23 hrs./Survived. [D. 
m 503, 
ft. 25 
5  days 
of  ore 
:isis. 
,'4 hrs 
36 hrs 
36 hrs 
]6 hrs 
Serum So  3, 
Jan. 29, I9z2, 
24 hoursbefore 
crisis.' 
D. 20 hrs. 
D. 24 hrs. 
D. 28 hrs. 
D. 36 hrs. 
D. 46 hrs. 
D. 6o hrs. 
Serum 503, 
Jan. 3o, *9x2, 
day of crisis. 
D. 22 hrs. 
D. 28 hrs. 
D. 36 hrs. 
D. 46 hrs. 
D. 36 hrs. 
D. 36 hrs. 
Serum 503, 
Feb.z4, z9zs. 
*  4 days 
after crisis. 
D.  28 hrs. 
D.  23  hrs. 
D.  36 hrs. 
D.  5o hrs. 
D.  5o hrs. 
D,  36 hrs. 674  Protective  Substances  in Human  Serum. 
Protection  of  Mice  against  Pneumococcus  IX  (Organism  from  Sputum  of 
Patient  503). 
Quantity of  ~uan-  : 
culture in  [ty of  Virulence;  Immune 
c.c.  rumin  no serum,  horse serum 
c.c. 
0.I  0.2 
0.0I  0.2 
0.0OI  0.2  D.  48 hrs  Survived. 
o.oooI  0.2  D.  3o hrs  Survived. 
o.oooox  o.2  D.  45 hrs  Survived. 
o.oooooi  o.2  D,  49 hrs  Survived. 
Serum 503, I 
Jan. 25,  ]  Serum 503, 
x9z2, 5 days]  Jan. 29, x9x2, 
before  / 24 hours before 
CI"ISlS.  Cl"fsi$.  /- 
D.  30 hrs. 
D.  3o hrs.  D. 46 hrs. 
D.  48 hrs.]  D.  46 hrs. 
3.48  hrs. /  Survived. 
:).  46 hrs.[  D.  46 hrs. 
Serum 503, 
Jdan. 3  o, I912, 
ay of crisis. 
D. 30 hrs. 
Survived. 
Survived. 
Survived. 
Survived. 
Serum 503  , 
Feb.  14  , 
I912, 14 days 
after crisis. 
F 
Survived. 
Survived. 
Survived. 
Survived. 
Experiment  9,--The  following  specimens  of  sera  (5Ol)  were  obtained  from 
a  patient  with  typical pneumonia  of  the  right  upper  lobe.  There  was  a  pseudo- 
crisis  on  the  fifth  day  of  the  disease,  and  a  true  crisis  on  the  following  day, 
after  which  the  temperature  remained  normal.  The  'pneumococcus  used  in  the, 
tests  was  isolated  from  the  patient's  sputum  and  the  virulence  raised  by  animal 
passage  until  o.oooooi  c.c.  of  a  twenty-four  hour  broth  culture  was  fatal  in 
thirty-six  hours.  The  blood  culture  was  negative  throughout  the  disease. 
Quantity 
of cukure 
in c.C. 
O.I 
O.OI 
O.OOI 
0.0001 
0.00001 
0.000001 
I 
Man-  I  CeOrnutrO.1  ~ty of  Virulence  ; 
no serum,  leg ulcer. 
0.2 
0.2 
0.2  ~i  36  hrs.[D.  36 hrs. 
0.2  D.  36 hrs.]D.  36 hrs. 
hrs.  36  0,2  36  hrs.ID. 
o.2  36  hrs. D.  36 hrs. 
Serum 5oi, 
Feb. x~, 
z9x2, 3 flays 
before 
crisis. 
D.  x8 hrs. 
36 hrs. 
36 hrs. 
DI  36 hrs. 
Serum 5oi, Feb. 
2i, xQx2, z day 
before crisis. 
Day of 
pseudocrisis. 
D.  18 hrs. 
D.  I8 hrs. 
D.  36 hrs. 
D. 36 hrs. 
D.  36 hrs. 
D.  36 hrs. 
Serum 5oi, Feb. 
23, I912, I day 
after crisis. 
D.  18 hrs. 
D.  i8 hrs. 
D.  z9 hrs. 
D.  36 hrs. 
D.  48 hrs. 
D.  36 hrs. 
Serum 5oi, 
Mar. ix, 
x912, x6 
days after 
crisis. 
D.  i8 hrs. 
D.  x8 hrs. 
D.  35 hrs. 
Survived. 
Survived. 
Survived. 
Experiment  /o.--The  serum  (5o2)  for  this  test  was  obtained  from  a  patient 
suffering  from  a  severe  attack  of  lobar  pneumonia.  The  temperature  fell  by 
lysis  on  the  eighth  day  of  the  disease,  reaching  normal  on  the  tenth  day.  The 
blood  cultures  were  negative.  The  pneumococcus  used  for  infection  of  animals 
was  obtained  from  the  patient's  sputum,  and  after  several  animal  passages 
o.oooooi  c.c.  of  a  twenty-four  hour  broth  culture  was  fatal  for  mice  in  thirty- 
six  hours. 
Quantity 
of culture 
in c.c. 
O.I 
O.OI 
O.OOI 
0.000I 
O.O000I 
O.OOOOOI 
)ufl/1- 
:ty of  Virulence  ; 
erum  no serum. 
2c.c. 
0.2 
o2 
O.2 
0.2  D.  36 hrs, 
0.2  24 hrs. 
0.2  36 hrs. 
Serum 502,  Serum 502, Feb, 
Control  Feb. zg,  2x, i9x2. 3 days 
i9z2  , 6 days :  before drop 
serum,  before drop  in tempera-  leg ulcer,  in tem-  ture.  perature.  ; 
).  18  hrs. D.  22  hrs.l  D. 36 hrs. 
hrs.  D.  35  hrs.]  D. 36  ).  24 hrs. 
).  36 hrs.  D.  36 hrs.]  D.  36 hrs. 
Serum 502, Feb. 
27, I9I~  , ISt 
day of  normal 
temperature. 
D.  x8 hrs. 
D.  30 hrs. 
D.  x8 hrs. 
D.  24 hrs. 
D. 35 hrs. 
D.  35 hrs. 
Serum 5o2, 
Mar. xI, 
I912, X  3 
days after 
normal 
temperature 
D.  18  hrs. 
D.  I8  hrs. 
D.  3o hrs. 
D.  22  hrs. 
D.  i8 hrs. 
D.  36 hrs. A.  R.  Dochez.  675 
Experiment  zL--The  serum  (554)  used  in  this  experiment  came  from  a 
patient with typical pneumonia of the left lower lobe.  The temperature fall was 
by crisis on the sixth day of the disease.  The blood culture was negative.  The 
pneumococcus  was  isolated  from  the  sputum  and  the  virulence  raised  until 
o.oooooi  c.c.  was  fatal  for  mice  in  thirty-six hours. 
Quantity of 
culture in 
c.c. 
0. I 
0.OI 
O.OOI 
O.O00I 
0.0000I 
O.O00OOI 
Quantity of 
serum in 
c.c. 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
Virulence ;  Control serum, 
no serum,  leg ulcer. 
D. 28 hrs  D. x8 hrs. 
D. 28 hrs  D. I8 hrs. 
O.  I8  hrs  Survived, 
D. 36 hrs.]  Survived. 
Serum 554. Mar. 
x6, x9xz,  i  day 
before crisis. 
D. i8 hrs. 
D.  I8 hrs. 
D. 28 hrs. 
D. 36 hrs. 
Serum 554, Mar. 
xS, z9zz, i2 hours 
after crisis. 
D. i8 hrs. 
D. 28 hrs. 
D. 3 days. 
D. 6 days. 
D. 3 days. 
Survived. 
Serum 554, Apr. 
5, z~x2, x 7 days 
alter crisis. 
D.  i8 hrs. 
D.  I8 hrs. 
D. 3 days. 
Survived. 
Survived. 
Survived. 
Experiment I2.--The serum  (538)  for this  experiment was obtained from a 
patient with  a  moderately severe attack  of lobar pneumonia.  The  temperature 
fell by crisis on the seventh day of the disease.  The blood cultures were nega- 
tive.  The  organism  used  was  a  pneumococcus  obtained from  the  patient's 
sputum.  The  virulence  after  animal  passage was  high,  and  o.oooooi  c.c.  of  a 
twenty-four hour  broth  culture  was  fatal  for  mice in  thirty-six hours. 
Quantity of  Quantity of 
culture in  serum in  Virulence ; 
c.c.  c.c.  no serum. 
O.I  O,2 
0.01  0.2 
0.00I  0.2 
o.ooo~"  o.2  D. 24 hrs 
o.ooooi  0.2  D. 36 hr.* 
O.O0000I  0.2  D. 36 hr~, 
Control serum, 
syphilis. 
D. 24 hrs. 
D. 24 hrs. 
D. 24 hrs. 
Serum 538  , Mar. 
x8, xg~, x day 
before crisis. 
D. 24 hrs. 
D. 24 hrs. 
D. 36 hrs. 
Serum 538, Mar. 
2x, zgz2, 36 hours 
alter crisis. 
D. I8 hrs. 
D. 24 hrs. 
D. 24 hrs. 
Survived. 
Survived. 
Survived. 
Serum 538  , Apr. 
5, z~2, z6 days 
alter crisis. 
D. x8 hrs. 
D. 18 hrs. 
D. 24 hrs. 
D. 24 hrs. 
D. 24 hrs. 
D. 36 hrs. 
Experiment /./.--The serum  (6o6)  for this  experiment was  obtained  from a 
patient with a  severe attack  of lobar pneumonia.  The temperature fell by lysis 
on  the  eleventh  day  of  the  disease,  but  remained  slightly  elevated  until  the 
seventeenth day.  The physical signs in the lungs cleared up  slowly.  The blood 
culture  showed  pneumococcus  on  the  seventh  day,  and  the  organisms  disap- 
peared  from  the  blood  on  the  tenth  day.  The  pneumococcus,  when  isolated, 
killed mice in the higher dilutions in  from three to  four  days. 676  Protective Substances in Human  Serum. 
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Experiment  z4.--The  serum  (553)  for  the  following  test was  obtained  from 
a  patient  with  a  moderately  severe  pneumonia  of  the  left  lower  lobe.  There 
was  a  pseudocrisis  on  the  fourth  day  of  the  disease.  The  true  crisis  occurred 
on  the  eighth  day  of  the  disease.  The  blood  cultures  were  negative.  The 
virulence  of  the  pneumoeoecus isolated  from  the  patient's  sputum could  not be 
raised  successfully,  so the  same  organism  was  used  for  infection  of  animals  as 
in  experiment  13. 
Quantity of 
culture in 
c.c. 
0.£ 
O.OI 
O.OOI 
O.O001 
O.O0001 
O.O0000I 
~uan-  Control 
ity of  ; Virulence ;  serum. 
erum  no serum,  syphilis. 
a  c.c. 
0.2  ~  [D.  40 hr 
o.2  ). 42 hrs.JD. 3o hr 
0.2  iD. 42  hrs.ID. 24 hr 
o.2  D.  4days.]D.  72 hr 
0.2  iD. 4days. D. 4day 
0.2  D.  48 hrs. D.  4day 
Serum 553, 
Mar. 5, x9x2, 
6 days be- 
fore crisis. 
D. 4 days. 
D. 4 days. 
D.4½ days. 
D. 4 days. 
Serum 553, Mar. 
7, ~9  x~, 4 days 
before crisis. 
Day of pseudo- 
cnsls. 
D. 40 hrs. 
D. 4~ days. 
D. 4 days. 
Survived. 
Serum 553, Mar. 
~x, xgx2, day 
of crisis. 
D. 24 hrs. 
D. 4o hrs. 
D. 40 hrs. 
Survived. 
Survived. 
Survived. 
Serum 553, 
Mar. ~6, 
x9xz, x  5 days 
after crisis. 
D. 40 hrs. 
D. 20  hrs. 
D. 5 days. 
D.  40 hrs. 
Survived. 
Survived. 
DISCUSSION. 
Specimens  of  sera  obtained  at  various  stages  of  the  disease  in 
fourteen patients have been studied.  The specimens of sera  from 
ten  of  these  patients  were tested  against  homologous  organisms. 
The  sera  from three of the cases were tested  against  a  stock or- 
ganism, Neufeld I, and from one case against an organism isolated 
from the blood of patient 6o6.  The appearance of protective sub- 
stances  is  more evident when sera  are tested  against  homologous 
organisms.  In  the ten groups  of  sera  tested  against  homologous 
organisms,  all but one exhibited at some time the power to protect 
mice against infection.  Of the four groups  of sera tested against 
the stock organisms, three showed at no time any protective power. 
In experiment 14, the serum obtained on the day of crisis protected 
against IOO lethal doses of an organism obtained from the blood of 
patient 6o5.  It has been shown by Neufeld and HaendeV that the 
immune bodies for various races of typical pneumococci are highly 
specific, and we have also found this to be the case in our study of 
the protective power of  an  immune serum produced  from a  type 
strain.  It is, therefore, evident that in the present study the results 
can only be of importance in the cases where homologous organisms 
were employed.  This is shown by experiment 8, in which the same 
specimens of sera were tested against two strains  of pneumococci, 
'  Neufeld,  F.,  and Haendel, Arb. a. d.  k. Gsndhtsamte,  t9Io,  xxxiv, 293. 678  Protective Substances in Human  Serum. 
one  a  stock  culture  and  the  other  an  organism  isolated  from  the 
patient's  sputum.  At  no  time  did  the  serum  protect  against  the 
stock  strain,  whereas  the  post-critical  sera  protected  regularly 
against  one  thousand  times  the  lethal  dose  of  the  homologous 
organism. 
The amount of protection afforded by the pneumonic sera exam- 
ined  has  varied  in  different  individuals.  In  comparison  with  the 
potency  of  sera  obtainable  by  active  immunization  of  larger  ani- 
mals,  it has been small.  The greatest amount of protection against 
strains  of maximum  virulence  is  seen in  experiments  4  and  8.  In 
both these instances  it was possible to protect  mice  with  specimens 
of  serum  obtained  after  the  crisis  against  o.ooi  of  a  cubic  centi- 
meter  of  a  broth  culture  of  a  highly  virulent  pneumococcus,  of 
which  o.oooooi  of  a  cubic  centimeter  of  the  same  culture  was 
fatal  for  mice  in  forty-eight  hours,  thus  affording  protection 
against one thousand times the lethal  dose, a  value that corresponds 
favorably with  that  of  some of  the  commercial  immune  sera.  In 
other  experiments  the  protective  power  of  the  sera  tested  varied 
from  ten  to  one hundred  times  the  lethal  dose. 
The time at which the appearance of immune bodies in the blood 
was demonstrable  varied  somewhat.  In only  four cases was  there 
any  protective  power  demonstrable  in  the  serum  obtained  before 
the  crisis.  In  experiment  I  protective  substances  were  present 
twelve hours before the drop in temperature.  Inasmuch  as no ear- 
lier specimen  of serum had been obtained  in  this  instance,  it  is  im- 
possible  to  say  how  long  these  bodies  had  been  present.  In  ex- 
periment  5  serum  obtained  two  days  before  the  temperature  fell 
showed slight  protective power,  but  no  greater  than  control  serum 
from  a  patient  with  chronic  endocarditis.  In  two  other  experi- 
ments,  8  and  14,  single  animals  that  had  received ante-critical  sera 
survived.  In seven cases pro,tective substances  either  appeared  for 
the  first  time  or  showed a  marked  increase  in  amount  at  the  time 
of crisis  or,  in case of lysis,  during  the period  when the  symptoms 
were abating.  In  some  of  these  instances  no  specimens  of  serum 
were  obtained  immediately  before  the  crises,  so  that  the  immune 
bodies may have  been  present  twenty-four hours  or longer  before 
the  disappearance  of  symptoms.  However,  in  experiment  4  the A.  R.  Dochez.  679 
specimen of serum  obtained  twenty hours  before the beginning of 
the critical drop in temperature  contained no protective bodies.  In 
two cases  the  serum  taken  during  the  period  of  defervescence ex- 
hibited  little  or  no  power  of protection,  even  against  homologous 
strains of pneumococcus, and  it was not for some time later,  in one 
case sixteen days,  that  the  presence of protective substances  in the 
blood  was  demonstrated.  The  sera  of  seven  patients  showed 
undiminished protective power as long as the individuals were under 
observation,--from  five to twenty days.  In five cases there  was a 
drop  in  the  protective  power  during  the  period  of  convalescence. 
This  diminution  varied  from  a  slight  loss  to  complete  absence  of 
protective  substances.  In  several  instances  there  was  a  slight  re- 
turn of protective power during late convalescence.  It was thought 
at  one time  that  the  disappearance  of antibodies  might  have  some 
connection  with  the  continuance  of  slight  fever  after  the  critical 
fall  of  temperature,  but  the  same phenomenon  has  been  observed 
in  patients  that  remained  afebrile  after the:  crisis. 
CONCLUSIONS. 
These  experiments  demonstrate  that  protective  substances  are 
usually present in the blood of patients  recovering from lobar pneu- 
monia.  As a  rule, the appearance of protective bodies in the blood, 
when demonstrable, coincides rather sharply with the period of crit- 
ical fall in temperature and the disappearance of symptoms.  These 
substances  are  not  present  in  the  blood  in .any  measurable  degree 
before the crisis,  but afterward they may reach  a  considerable con- 
centration.  In  certain  instances,  protective  substances  either  be- 
come evident some time after the occurrence of the crisis, or cannot 
be  demonstrated  at  any  period  of  the  disease.  Experiments  in 
which  it  is possible to test  serum  against  an  homologous  strain  of 
pneumococcus yield in  the majority  of  cases evidence of the  pres- 
ence of protective bodies; whereas in those in which stock cultures 
are used,  the serum,  as a  rule,  shows no protection.  The  develop- 
ment of specific protective substances in the serum of patients  with 
lobar pneumonia  suggests  that  these bodies may play a  part  in  the 
mechanism  of recovery. 